Navigation Links
Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
Date:9/10/2009

imaging.cancer.gov/clinicaltrials/imaging/" target="_new">RECIST criteria. No patient in any dose group exhibited any signs of acute neurotoxicity, which is a major adverse side-effect of the approved DACH platinum, Eloxatin, and ProLindac was well tolerated overall.

The recent Phase 2 recurrent ovarian study explored three different dose levels and two dosing regimens of ProLindac as a monotherapy treatment for advanced ovarian cancer, to provide data on the monotherapy anticancer activity and safety of ProLindac. Of patients eligible for evaluation according to standard RECIST criteria, clinically-meaningful disease stabilization was achieved in 42% of all patients, and 66% of all patients in the higher dose groups. Sustained and significant reductions in Ca-125, the established specific serum marker for ovarian cancer, were also observed in several patients.

"Access is extremely pleased with the clinical progress to date, and look forward to initiation of clinical trials looking at ProLindac in combination with commonly used chemotherapies," stated Jeffrey Davis, President & CEO. "Our partners in the Far East hosted Access together with key opinion leaders in oncology indications to discuss various potential protocol options, and hope to start enrolling patients in up to three combination trials by the end of the year, depending upon regulatory approvals of the trial protocols and certain other matters."

About ProLindac(TM):

ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion.
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
2. NuAire Laboratory Economic Stimulus Package -- Free Accessories or Factory Options
3. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
4. Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights
5. Access Pharmaceuticals CEO Interviewed on Financial Website
6. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
7. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
8. Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress
9. Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China
10. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
11. Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015 The Dohmen Company today announced ... MBA as Chief Science Officer (CSO) of Dohmen ... role, Dr. Floyd will lead Dohmen,s growing regulatory ... pre-commercial and post approval outsourced services in quality, ... Dr. Floyd brings decades of experience leading global ...
(Date:9/1/2015)... 1, 2015   Medfusion, Inc., a ... between doctors and patients, today announced a $3 ... -based venture capital firms.   ... with Bull City Venture Partners and Hatteras Venture ... and Executive Chairman. "Both firms, experience working at ...
(Date:9/1/2015)... ... September 01, 2015 , ... Research conducted ... Los Angeles, Boston University School of Medicine, Frederick National Laboratory for Cancer Research, ... world’s first multidisciplinary Open Access journal. , Christopher Ryan PhD, of Synedgen, ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Global Supply Chain ... management and resiliency practitioners with luminaries and thought leaders to advance the professional ... for their innovations and performance excellence. At that time its principle sponsor, ...
Breaking Biology Technology:Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 3Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 3
... Technology Network sat down with Tom Still, the president ... the basic tenets of the organization and initiatives Still ... space grow. Read Part One. , ... the Wisconsin Technology Council has encountered and what are ...
... started a discussion about what people are good for ... blah, blah out there about the complexity of current ... judgment, greater flexibility, improved communication and more dynamic creativity. ... pragmatic courses of action that apply the best source ...
... Four Wisconsin-based companies have be listed in Computerworlds top ... three of which landed within the top 25. Schneider National, ... company this year. American Family Insurance and ... respectively, and Lands End, Inc. came in at ...
Cached Biology Technology:WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 2WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 3WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 4Analog people in the Digital Revolution, part II 2Analog people in the Digital Revolution, part II 3
(Date:8/6/2015)... Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon Valley ... Crossmatch is a world leader in multi-factor identity ... are helping federal agencies and commercial organizations achieve ... "The vast majority of network breaches ...
(Date:8/5/2015)... 5, 2015 The biosensors market is proving ... penetration into newer sectors, and development of devices resulting ... space has seen the entry of multiple participants each ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... of the Global Biosensors Market ( http://www.frost.com/nee9 ), ...
(Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... will develop and coordinate a strategic federal research ... breast cancer. The 19-member Interagency Breast Cancer and ... the National Institute of Environmental Health Sciences (NIEHS), ... to review all breast cancer research efforts conducted ...
... for Age Research have successfully used human induced pluripotent ... Disease (PD). The research, which validates a scalable ... be used to manufacture the type of neurons needed ... the use of iPSC,s in various biomedical applications. Results ...
... package developed by a professor at the Virginia Bioinformatics ... understand the workings of biochemical networks now features an ... benefits to its users. In development for over ... collaboration between VBI Professor Pedro Mendes, research groups at ...
Cached Biology News:New breast cancer committee to establish federal research agenda 2New breast cancer committee to establish federal research agenda 3Scientists successfully use human induced pluripotent stem cells to treat Parkinson's in rodents 2Systems biology software package developed at VBI is now open source for all users 2
... data collection and automation that is controlled from ... Excel , Pre-configured library of interfaces for ... can be added and configured by the user ... into one spreadsheet , Allows for ...
...
Peptide-affinity Purified Polyclonal Antibody to MAML1 / Mastermind Peptide with sequence VLPTCPMAEFALPR, from N Terminus of the protein sequence according to NP_055572....
One unit is equal to 10Kb (insert DNA + vector). The final cost will increase or decrease according to the final assembled genome size. The price does not include genome annotation....
Biology Products: